Omega Therapeutics Inc Stock, NASDAQ:OMGA
140 First Street, Suite 501, Cambridge, Massachusetts 02141
United States of America
Number of Employees: 117
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.